MDA5 assembles into a polar helical filament on dsRNA

Melanoma differentiation-associated protein 5 (MDA5) detects viral dsRNA in the cytoplasm. On binding of RNA, MDA5 forms polymers, which trigger assembly of the signaling adaptor mitochondrial antiviral-signaling protein (MAVS) into its active fibril form. The molecular mechanism of MDA5 signaling i...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 109; no. 45; pp. 18437 - 18441
Main Authors Berke, Ian C., Yu, Xiong, Modis, Yorgo, Egelman, Edward H.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 06.11.2012
National Acad Sciences
Subjects
Online AccessGet full text
ISSN0027-8424
1091-6490
1091-6490
DOI10.1073/pnas.1212186109

Cover

More Information
Summary:Melanoma differentiation-associated protein 5 (MDA5) detects viral dsRNA in the cytoplasm. On binding of RNA, MDA5 forms polymers, which trigger assembly of the signaling adaptor mitochondrial antiviral-signaling protein (MAVS) into its active fibril form. The molecular mechanism of MDA5 signaling is not well understood, however. Here we show that MDA5 forms helical filaments on dsRNA and report the 3D structure of the filaments using electron microscopy (EM) and image reconstruction. MDA5 assembles into a polar, singlestart helix around the RNA. Fitting of an MDA5 homology model into the structure suggests a key role for the MDA5 C-terminal domain in cooperative filament assembly. Our study supports a signal transduction mechanism in which the helical array of MDA5 within filaments nucleates the assembly of MAVS fibrils. We conclude that MDA5 is a polymerization-dependent signaling platform that uses the amyloid-like self-propagating properties of MAVS to amplify signaling.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Edited by Stephen C. Harrison, Howard Hughes Medical Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, and approved September 27, 2012 (received for review July 17, 2012)
Author contributions: I.C.B., Y.M., and E.H.E. designed research; I.C.B., X.Y., and E.H.E. performed research; I.C.B., X.Y., and E.H.E. contributed new reagents/analytic tools; I.C.B., X.Y., Y.M., and E.H.E. analyzed data; and I.C.B., Y.M., and E.H.E. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1212186109